Subscribe to stay informed!
Malvern’s PhaseBio saw its shares soar after it signed a financing and co-development deal with California-based SFJ Pharmaceuticals worth up to $120…
PhaseBio, a small biopharmaceuticals firm in Malvern, has seen its stock nearly triple in the last six months following its IPO, writes Joseph DiStefano for…
PhaseBio Pharmaceuticals has signed a deal with Duke University, giving the university exclusive rights to its drug-delivery technology for use in treating cancer.
However…
Before we send you to this site, please subscribe to our daily newsletter.